Another Medtronic Preemption Case Appealed to High Court
This article was originally published in The Gray Sheet
Executive Summary
A case questioning whether patients can sue device makers if a PMA-approved device is marketed for off-label uses may be headed to the Supreme Court, following a recent petition for a writ of certiorari.
You may also be interested in...
High Court Won’t Hear InFuse Off-Label Preemption Case
The case would have tested whether manufacturers could be held liable if an FDA-approved device injured a patient when the product was employed for an off-label, unapproved use. The Oklahoma Federal Court and the 10th Circuit Court of Appeals had both previously ruled in industry’s favor.
In Case You Missed It: Top 10 "Gray Sheet" Stories In September
Our most popular stories last month focused on tips from FDA experts on facility inspections, various legal trends, and Robert Califf's nomination to head FDA, among other topics.
Off-label, Failure-to-Warn Preemption Cases May Head to Supreme Court
While federal preemption of state suits for PMA-approved has been strongly validated by the Supreme Court, two types of plaintiffs' claims in particular offer the potential for the PMA preemption device to be considered once again by the high court, according to Mayer Brown partner Andrew Tauber.